All news from Anaesthesiology

Poor Sleep Quality Predict Atrial Fibrillation

The study was to determine whether poor sleep itself is a risk factor for AF. Poor sleep quality appears to be an important risk factor for atrial fibrillation, report scientists in the first study of its kind to demonstrate a relationship between poor sleep quality independent of sleep apnea and a higher risk of atrial fibrillation (AF). The study was published in HeartRhythm.

Stochastic Turing Patterns Exhibited by Engineering Bacteria

A new study has brought science one step closer to a molecular-level understanding of how patterns form in living tissue. The researchers engineered bacteria that, when incubated and grown, exhibited stochastic Turing patterns: a 'lawn' of synthesized bacteria in a petri dish fluoresced an irregular pattern of red polka dots on a field of green.

Analysis Of Shared Heriability In Common Disorders Of Brain

Psychiatric disorders such as schizophrenia and bipolar disorder often run in families. In a new international collaboration, researchers explored the genetic connections between these and other disorders of the brain at a scale that far eclipses previous work on the subject. The team determined that psychiatric disorders share many genetic variants, while neurological disorders appear more distinct.

Implanting A Micro Pacemaker System In The Pericardial Space

Researchers have demonstrated the feasibility of implanting a micro pacemaker system in the pericardial sac surrounding the heart a breakthrough that may open up new cardiac pacing options for children and adults.

The micro pacemaker inserted through a single tiny incision avoids an invasive surgical procedure and the complications related to long pacemaker leads. The study, "Minimally Invasive Implantation of a Micro pacemaker into the Pericardial Space." The study was published in Circulation: Arrhythmia and Electrophysiology.

New Influenza Drug's Mode of Action Detailed

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018. Scientists from EMBL Grenoble have now investigated the drug's mode of action in detail and uncovered possible mechanisms by which viral resistance to it could emerge. Scientific Reports published the results of the study. 

Drug Problem in Bangladesh Requires Collective Solutions

Bangladesh and other UN Member States made public commitments to jointly reduce abuse, illicit trafficking and the harm that drugs cause to societies. To tailor measures to the specific needs of children, youth and other vulnerable members of society. To make parents more supportive, social environments healthier and education and vocational training equally accessible. There was one unequivocal appeal: “Put People First.”